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Summary
To comprehensively investigate the genetic architecture of growth and obesity, we performed 
Bayesian analyses of multiple epistatic quantitative trait locus (QTL) models for body weights at 
five ages (12 days, 3, 6, 9 and 12 weeks) and body composition traits (weights of two fat pads and 
five organs) in mice produced from a cross of the F1 between M16i (selected for rapid growth 
rate) and CAST/Ei (wild-derived strain of small and lean mice) back to M16i. Bayesian model 
selection revealed a temporally regulated network of multiple QTL for body weight, involving 
both strong main effects and epistatic effects. No QTL had strong support for both early and late 
growth, although overlapping combinations of main and epistatic effects were observed at adjacent 
ages. Most main effects and epistatic interactions had an opposite effect on early and late growth. 
The contribution of epistasis was more pronounced for body weights at older ages. Body 
composition traits were also influenced by an interacting network of multiple QTL. Several main 
and epistatic effects were shared by the body composition and body weight traits, suggesting that 
pleiotropy plays an important role in growth and obesity.
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1. Introduction
Obesity is a highly prevalent condition with adverse health effects and multifactorial 
etiology. Though highly heritable, the genetic architecture of obesity is quite complex and 
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remains to be fully elucidated (Allison et al., 2002; Dong et al., 2003; Pomp et al., 2004). 
Some genes involved in predisposition to obesity may only be detectable with models that 
accommodate epistasis. Indeed, some studies have shown that obesity and other diseases in 
both humans and rodents is influenced by epistasis (Brockmann et al., 2000, 2004; Allison et 
al., 2002; Yi et al., 2004a, b; Carlborg and Haley 2004). These studies have shown that some 
QTL may lack marginal effects but significantly affect the trait if they are evaluated jointly 
with other loci. Therefore, more explicit analysis of complex interactions among multiple 
genes is desired in discovering of genes underlying obesity and in better understanding how 
genetic predisposition is regulated.
We report here the detection of epistatic QTL for growth and obesity in a backcross 
population derived from two diverse mouse populations: an inbred line (M16i) derived by 
brother-sister mating from a line that had undergone long-term selection for rapid post-
weaning weight gain, and an inbred line (CAST/Ei) derived from wild mice. Using 
traditional interval mapping and multivariate techniques (Lander & Botstein, 1989; Haley & 
Knott, 1992), several genomic regions have been identified to harbor QTL influencing 
principal components of organ weights and limb bone lengths in this backcross (Pomp, 
1997; Leamy et al., 2002). However, other obesity-related traits that were measured in this 
population, e.g., body weights and fat pads, have not been investigated. Furthermore, 
statistical methods for mapping multiple and epistatic QTL were not previously employed to 
analyze these data. In this study, we used the Bayesian model selection method developed by 
Yi et al. (2005) to comprehensively investigate the genetic architecture of body weights, fat 
pad measurements and organ weights.
2. Materials and Methods
Mouse lines and crosses
Mice used in this study were from two distinct genetic backgrounds: the inbred high-growth 
selection line, M16i, and the inbred line of wild origin, Mus musculus castaneus (CAST/Ei; 
The Jackson Laboratory, Bar Harbor, ME). M16i originated from an ICR base and was 
derived from M16, which underwent long-term selection for rapid postweaning (3 to 6 wk) 
weight gain (Hanrahan et al., 1973; Eisen, 1975). ICR stands for Institute for Cancer 
Research, an albino random bred mouse line. The M16 line is characterized by increased 
growth rates and body weights and moderate obesity (Allen et al., 2004). CAST/Ei (CAST), 
one of the four morphologically and biochemically distinct Mus musculus subspecies, 
exhibits small size and a lean body composition.
Development of the backcross population and details of animal husbandry have been 
described earlier (Leamy et al., 2002). Briefly, CAST males were mated to M16i females, 
and seven F1 males were backcrossed to M16i females, resulting in 54 litters with a total of 
421 mice (213 males, 208 females) reaching adult age (12 week). All mice were reared in an 
environment of 21EC, 55% relative humidity, and a light:dark cycle of 12h:12h, following 
NIH guidelines for animal care. At birth (day 0), litters were standardized to a postnatal 
fraternity size of 10. Pups were weaned at day 21 and housed in groups of 2–4 per cage by 
sex. Mice were provided ad libitum access to water and feed (Purina Mouse Chow 5015 
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from mating until weaning and Purina Laboratory Chow 5001 from weaning and throughout 
phenotypic evaluation).
Phenotypic traits and markers
Body weights were recorded on all backcross mice at day 12 and at 3, 6, 9 and 12 weeks of 
age (12d, 3wk, 6wk, 9wk and 12wk). Each mouse was killed at 12 wk of age, and a tail clip 
was frozen for later extraction of genomic DNA. Heart (HRT), liver (LIV), spleen (SPL), 
right kidney (KID), right epididymal (males) or perimetrial (females) fat pad (GON) and 
right hindlimb subcutaneous fat pad (SUB) were weighed (wet weights) in all mice. An 
additional trait analyzed was FAT, the sum of GON and SUB. The right testis (TES) was 
weighed in male mice.
Ninety-two fully informative microsatellite markers spanning the 19 autosomes were 
genotyped in the backcross sample (Leamy et al., 2002). Genotypes were determined by 
standard PCR and agarose gel electrophoresis protocols. The mating design used in this 
study did not enable screening of the sex chromosomes. Marker linkage maps were 
generated with MAPMAKER/EXP (Lincoln et al., 1992) as described by Leamy et al. 
(2002).
Statistical analyses
Prior to QTL analyses, phenotypic data were adjusted by obtaining residuals from a general 
linear model including environmental effects attributed to sex, litter size, sire and family. 
Residuals were used as new phenotypes in the QTL analysis. To search for QTL across the 
entire genome, we partitioned each chromosome with a 1-cM grid, resulting in 1214 ( = H ) 
possible loci across the genome, and assumed that the possible QTL occur at these fixed 
loci. The problem of inferring the number and locations of multiple QTL is equivalent to the 
problem of selecting a subset of 1214 possible loci that fully explains the genetically 
determined proportion of the phenotypic variation. Although any complex trait may be 
influenced by many QTL, the number of detectable QTL is much smaller than H. Using the 
Bayesian model selection framework of Yi et al. (2005), we placed a constraint on the upper 
bound of detectable QTL ( L ) and restricted attention to models with fewer than L QTL. 
The phenotypic values can be expressed as
where n is the number of mice; yi is the phenotypic value of the ith mouse; µ is the overall 
mean; xiq is the indicator variable denoting the genotype of putative QTL q for mouse i and 
is defined by 0.5 or – 0.5 for the two genotypes, CM and MM, where C and M represent the 
CAST and M16i alleles; aq represents the main effect of putative QTL q; bq1q2 is the 
epistatic effect between QTL q1 and q2; γq is a binary indicator variable for the main effect 
of putative QTL q, taking value one if QTL q has a main effect and zero otherwise, and 
γq1q2 is a binary indicator variable for the epistatic effect between QTL q1 and q2, taking 
value one if QTL q1 and q2 interact and zero otherwise; and ei is the residual error assumed 
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to follow N(0, σ2), where σ2 is the residual variance. Note that the introduction of the effect 
indicators facilitates setting up MCMC algorithms (Yi et al. 2005).
In the above model, the main effect, aq, quantifies the difference between genotypic values 
of CM and MM. Therefore, a positive (negative) main effect implies that the CAST allele 
promotes (reduces) the phenotype. Similarly, a positive (negative) epistasis promotes 
(reduces) the phenotypes of mice with double homozygotes (MM/MM) and double 
heterozygotes (CM/CM) at the corresponding two loci. Additionally, QTL analyses for all 
the fat pads and the organ weights were performed including 12wk as a covariate in the 
above model. This adjustment can remove any linear influence of body weight on the fat 
pads and the organ weights and thus attempts to identify alternate sets of QTL involved in 
different pathways responsible for the fluctuating patterns of phenotypic and genetic 
correlations observed among the various traits.
Based on the above multiple epistatic QTL model, we used the Bayesian model selection 
method developed by Yi et al. (2005) to jointly infer the number, positions, main and 
epistatic effects of multiple QTL. Our approach proceeded by setting up a likelihood 
function for the phenotype based on the above model and assigning prior distributions to all 
unknowns in the model. These induced a posterior distribution on the unknown quantities 
that contains all of the available information for inference of the genetic architecture of the 
trait. We first analyzed the data using the interval mapping method based on a single QTL 
model (Lander and Botstein 1998), and then used the number of significant QTL detected in 
the interval mapping to choose an upper bound of detectable QTL and specify prior 
distributions for the indicator variables of main and epistatic effects. A LOD score of 3.3 
was used to assess statistical significance at the 5% genome-wide level (Lander & Kruglyak, 
1995). This threshold value approximately equaled those obtained by permutation tests 
(Leamy et al. 2002). The upper bound of detectable QTL was then set to be 
, where lm is the number of main-effect QTL detected in the interval 
mapping. The prior probabilities for the indicators of main effects and epistatic interactions 
were chosen to be lm/L and , respectively (Yi et al., 2005). The 
positions of QTL were independent and uniformly distributed over the H possible loci. We 
used non-informative distributions for and σ2. The prior for each genetic effect was chosen 
to be the hierarchical mixture prior N(0, γσ2(xTx)−1), where γ and X are the effect indicator 
and the vector of the coefficients for the corresponding effect, respectively.
The Markov chain Monte Carlo (MCMC) algorithm developed by Yi et al. (2005) was 
employed to generate posterior samples from the joint posterior distribution of all unknowns, 
by updating each parameter from its conditional posterior distribution in each of iterations. 
The MCMC algorithms were started with no QTL in the model. In each analysis, the 
MCMC sampler was run for 4×105 cycles after discarding the first 2000 cycles for the burn-
in period. The chain was thinned (saved one iteration in every 20 cycles) to reduce serial 
correlation in the stored samples so that the total number of samples kept in the posterior 
analysis was 2×104. The stored samples (posterior samples) were used to infer the genetic 
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architecture of the trait analyzed. Convergence diagnostics assessed by the R package 
CODA (Plummer et al. 2004) showed that our algorithm performed well.
Each locus may affect the trait through its main effects and/or interactions with other loci 
(epistasis). Therefore, the larger the main effect and/or epistatic effects of a locus, the more 
frequently the locus is included in the model. This can be measured by the posterior 
inclusion probability of each possible locus ζh(h=1,2, …,H), p(ζh|y), estimated as the 
frequency that the locus ζh appeared in the posterior samples, where y is the vector of 
phenotypic values. The most likely position of QTL in a certain region was estimated as the 
locus that produces the highest posterior inclusion probability. From p(ζh|y), we obtained the 
cumulative distribution function per chromosome, defined as  for any 
position x on chromosome c. The fact that the cumulative distribution function at last 
position is greater than one provides evidence of multiple QTL at the corresponding 
chromosome. The posterior inclusion probability of an epistatic effect between two loci was 
estimated as the frequency that the epistasis appeared in the posterior samples. We reported 
all epistatic effects with the cumulative posterior inclusion probabilities for the 
corresponding chromosomes greater than 10%. The Bayes factors of these interactions, 
defined as the ratio of posterior and prior probabilities, are fairly high (>20) (Yi et al. 2005). 
The main effect and the proportion of phenotypic variance explained by the main effect at 
any locus were calculated using the posterior samples containing the locus. Similarly, we 




Interval mapping detected significant chromosomal intervals for all age-specific body 
weights: chromosomes 4 and 18 for 12d, chromosomes 1 and 18 for 3wk, chromosomes 1 
and 2 for 6wk, chromosomes 2 and 15 for 9wk, and chromosomes 2, 11 and 15 for 12wk 
(Table 2). There were additional suggestive QTL detected for body weight at each age, with 
LOD scores close to the threshold used (not shown here). Some chromosomes (e.g., 2 and 
15) showed two peaks.
There was strong evidence for age-dependent genetic regulation, with no single main-effect 
QTL being present at all ages. QTL present in proximal chromosome 4 affecting weight at 
the preweaning age of 12d was not present at older ages. Two other QTL with strong main 
effects on body weights of mice at weaning (3wk), but not on older mice, were located in the 
central regions of chromosomes 1 and 18, respectively. Conversely, significant and strong 
QTL located in the central region of chromosome 2 for body weights of older mice (6wk, 
9wk and 12wk) was not evident for body weights of younger mice. In addition, 
chromosomes 11 and 15 also harbored QTL affecting body weight of older mice only.
Profiles of posterior inclusion probabilities for each locus across the genome and cumulative 
posterior probabilities for each chromosome are depicted in the top panel of Figure 1. The 
main effects of QTL detected in the interval mapping were also detected in the Bayesian 
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analysis of the epistatic model. Peaks of the profiles of posterior inclusion probability 
overlapped those of LOD scores. The epistatic analyses found further age-specific QTL. For 
example, the non-epistatic analysis failed to detect QTL on chromosomes 1 and 18 affecting 
body weights of older mice, but the presence of such QTL was found in the epistatic model 
with a high posterior inclusion probability (~70%) for 9wk and 12wk. The posterior modes 
of these two epistatic QTL were close to the markers D1MIT140 and D18NDS1, 
respectively, for both 9wk and 12wk. Although the main effects of these QTL were 
relatively weak, they affected body weights of older mice mainly through epistatic 
interactions. The epistatic interaction between chromosomes 1 and 18 was included in the 
epistatic model with probability of ~60% and ~50%, respectively, for 9wk and 12wk (Table 
5). However, this interaction did not affect body weights of younger mice.
The number of epistatic interactions varied temporally. Variations of body weight at older 
ages (6wk, 9wk and 12wk) included more epistatic effects than at younger ages (12d and 
3wk). For all ages, there were a total of eight chromosomes involved in interactions. The 
most active was chromosome 1, which interacted with four other chromosomes for body 
weights at different ages. Other frequently involved chromosomes included 2, 13 and 18. 
Three two-way interactions (chromosomes 1 and 18, 1 and 4, and 2 and 13) were observed 
at both 9wk and 12wk. However, other detected epistatic interactions affected body weight 
at only one time point.
Detected QTL showed a complex pattern of genetic effects on body weight. Profiles of the 
location-wise main effects and the proportion of phenotypic variance explained by the main 
effects are displayed in the bottom panel of Figure 1. Almost all loci across the genome 
showed positive main effects on body weights of younger mice but negative main effects on 
body weights of older mice. This finding implies that inheriting a CAST allele at any locus 
increased body weights at younger ages, but reduced body weights of older mice. The main 
effects of the strongest QTL on chromosome 2 accounted for ~15% of the phenotypic 
variances of 9wk and 12wk. The proportions of the phenotypic variances contributed by the 
main effects of other detected QTL ranged from 1 to 11%.
Estimates of epistatic effects and proportions of phenotypic variances explained by these 
epistatic interactions (Table 5) demonstrate that each interaction explained a low (but 
detectable) percentage of the phenotypic variance, ranging from 1.3% to 4.1%. A positive 
(negative) epistasis promotes (reduces) the phenotypes of mice with double homozygotes 
(M16i/M16i and M16i/M16i)) and double heterozygotes (M16i/CAST and M16i/CAST) at 
the corresponding two loci. All interactions detected at younger ages (12d, 3wk and 6wk) 
were estimated to be negative. For body weights of older mice (9wk and 12wk), both 
positive and negative epistatic effects were observed. For example, the interaction of 
chromosomes 1 and 18 was positive for 9wk and 12wk, while the interaction of 
chromosomes 2 and 13 was negative for body weights at 6wk, 9wk and 12 wk.
Fat pad weights
ML interval mapping detected significant QTL for individual fat pad weights (GON and 
SUB) and the composite trait FAT on chromosomes 2, 13 and 15 (Table 3). The strongest 
QTL was identified on chromosome 2 at 77 cM with LOD scores ranging from 17–20 for 
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the three fatness traits. This QTL also had the largest main effect on body weights at ages of 
9wk and 12wk. As observed for body weight, chromosome 15 showed multple peaks; the 
highest peak (LOD of ~5) is observed at 35 cM, while additional sub-peaks are seen above 
the significance threshold in the interval 14 to 25 cM. Chromosome 13 was detected to 
influence the fatness traits.. This fat-specific region did not influence body weights or 
weights of the organs measured in this study.
As shown in the profiles of posterior inclusion probability and cumulative function, QTL on 
chromosomes 2, 13 and 15 were also detected in the Bayesian analysis of the epistatic model 
(Figure 2). Peaks of the profiles of posterior inclusion probability overlapped those of LOD 
scores. Similarly to body weights at older ages, the QTL on chromosomes 2 and 15 had 
negative main effects. However, the fat-specific QTL on chromosome 13 had positive 
effects, indicating that the presence of a CAST allele increased fat. The three main-effect 
QTL on chromosomes 2, 13 and 15 were estimated to explain ~18%, 4% and 3% of the 
phenotypic variances, respectively.
Analyses of epistasis found strong evidence for QTL on chromosomes 1, 18 and 19 with 
high cumulative probabilities (close to 1) for all three fat depot traits, unadjusted for body 
weight, and suggestive evidence of QTL on chromosomes 6, 7, 11 and 14. The QTL on 
chromosomes 1, 18 and 19 were estimated to have weak main effects and thus were detected 
in the epistatic model mainly due to epistatic interactions. The posterior modes of these three 
epistatic QTL were close to the markers D1MIT140, D18NDS1 and D19MIT11, 
respectively, for all three fat pads. Table 6 shows epistatic interactions between 
chromosomes with >10% of posterior inclusion probability. There were a total of 10 
chromosomal regions involved in interactions, including the regions with strong main effects 
on chromosomes 2, 13 and 15 as well as several other regions with weak main effects. As 
for body weights, interactions among the chromosomal regions with strong main effects 
(chromosomes 2, 13 and 15) were negative, and conversely, all other interactions involving 
at least one region with weak main effect were positive.
The strongest interaction for fat occurred between QTL on chromosomes 1 and 18, which 
also strongly influenced the phenotypic variation of body weights at 9 and 12 weeks. This 
interaction was included in the epistatic model with high probabilities and explained ~5% of 
the phenotypic variances for all three fat phenotypes. A region of chromosome 19 was found 
to interact with chromosomes 15 and 7. The interaction between the regions of 
chromosomes 19 and 15 was included in the model with ~50% and 65% of probability, and 
explained ~2% and 3% of the phenotypic variances for FAT and GON, respectively. Two 
interactions involving two main-effect QTL, chromosomes 2 and 13 and chromosomes 13 
and 15, were found to influence the fat traits. The first was included in the epistatic model 
with ~96% and 55% of probabilities and explained ~3% and 2% of the phenotypic variances 
for GON and FAT, respectively. The latter appeared to affect all three traits and explained 
~2% of the phenotypic variances.
As seen in the bottom panels of Table 3 and Figure 3, the inclusion of 12wk as a covariate in 
the analyses influenced detection of QTL for fat depots. When removing variation due to 
12wk from the fat traits, both interval and Bayesian mapping revealed activity of QTL on 
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chromosomes 5, 14 and 17, where there had been no QTL detected previously for the 
unadjusted traits. These fat-specific main effects were positive on chromosomes 5 and 17 
and negative on chromosome 14, and explained 3% to 6% of the phenotypic variances. 
When adjusted by 12wk, the QTL on chromosome 2 still influenced fat traits, indicating that 
this QTL likely has pleiotropic effects on body weight and fatness. Conversely, the main 
effect on chromosome 15 was eliminated after adjustment for body weight, suggesting that 
this locus had increased fat pad weights simply in proportion to increases in overall weight. 
Most of the strong epistatic interactions detected for unadjusted fat traits, e.g., chromosomes 
1 and 18, 2 and 13, and 15 and 19, were still found to influence fatness after adjustment for 
body weight (Table 6). The posterior modes of these epistatic QTL and the sign of these 
pleiotropic interactions remained unchanged.
Organ weights
Interval mapping for organ weights identified significant main-effect QTL influencing LIV 
on chromosomes 2 and 11, SPL on chromosomes 4 and 9, and KID on chromosomes 1 and 
18. (Table 4). Inclusion of 12wk as a covariate in the model did not influence the results for 
HRT and TES, but greatly influenced the detection of QTL for LIV, SPL and KID. The 
significant QTL on chromosomes 2 and 11 for LIV were removed and lessened, respectively, 
when adjusted by 12wk. However, new QTL were found for KID on chromosomes 2 and 3 
and for SPL on chromosomes 2 and 10 (Table 4).
Bayesian analysis of the multiple epistatic model identified all main-effect QTL detected by 
interval mapping for both the unadjusted and the adjusted traits (Figures 4 and 5). Peaks on 
the profiles of the posterior inclusion probability overlapped those of the LOD curves. As 
seen for body weights and fat traits, however, the curves of the posterior inclusion 
probability were much sharper than the LOD curve and thus provided more precise 
estimation of QTL locations. For both unadjusted and adjusted KID, for example, LOD 
score curves on chromosome 1 significantly spanned the whole chromosome, but curves of 
the posterior inclusion probability concentrated on a narrow region near D1MIT140 with 
high posterior cumulative probabilities. For unadjusted LIV and adjusted KID, there were 
three peaks on the profiles of the posterior inclusion probability on chromosome 2, and the 
posterior cumulative probabilities were 1.4, indicating the possibility of multiple QTL.
The posterior mean profiles of location-wise main effects and variances explained by the 
main effects are displayed in Figures 4 and 5. For LIV and SPL, main effects in all 
significant regions were negative, similar to the patterns for body weights at older ages and 
fat traits. Conversely, main effects in most chromosomal regions for HRT and TES were 
positive, indicating that a CAST allele promotes HRT and TES but reduces LIV and SPL. 
For KID, some chromosomes (e.g., 1, 2 and 3) showed positive effects and others (e.g., 18) 
negative. Main effects explained ~5% to 17% of the phenotypic variances.
Organ weights are influenced by epistatic interactions (Table 7). The strongest interaction 
occurred between chromosomes 1 and 18 for KID, which also greatly influenced the 
variations of body weights at older ages and fat traits. This interaction was included in the 
models with 99% and 30% of posterior probability and explained ~5% and 2% of the 
phenotypic variances for unadjusted and adjusted KID, respectively.
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Bayesian epistatic QTL Mapping
The introduction of genome-wide screening to detect QTL affecting complex traits has 
recently drawn renewed interest to the importance of epistasis in the evolution and etiology 
of disease-associated traits such as obesity and type 2 diabetes (Warden et al., 2004; 
Carlborg and Haley 2004; Chesler et al., 2005, Moore, 2005; Segrè et al., 2005). This 
interest has fueled research into statistical models traditionally used to interpret epistasis 
(Yang, 2004; Zeng et al., 2005) and has led to refined methods of estimating epistasis in 
QTL analyses, (Carlborg et al., 2000; Yi & Xu, 2002; Yi et al., 2003, 2005; Zhang & Xu, 
2005).
We adopted a Bayesian model selection method, (Yi et al., 2005), to search for epistatic 
QTL across the entire genome with effects on body weight, obesity and organ weights. Our 
Bayesian method used multiple QTL models and jointly inferred the number of QTL, their 
genomic positions, and their main and epistatic effects simultaneously. Therefore, this 
Bayesian mapping method could detect multiple QTL with any combination of main and 
pairwise epistatic effects in an interactive fashion. The Bayesian framework incorporates our 
prior information into analysis, and provides a robust inference of genetic architecture that 
incorporates model uncertainty by averaging over all possible models (Yi et al. 2005).
Our present Bayesian method separately analyzes each of multiple traits. However, the 
phenotypes investigated in this study present significant correlations (not shown here), 
showing that joint analysis of these phenotypes may improve power for detecting QTL. 
Especially, body weights at five ages describe growth and should be better treated as a 
function-valued trait (Wu et al. 2005). Joint analysis of multiple phenotypes can provide 
formal procedures to investigate the genetic mechanisms such as pleiotropy and close 
linkage (Jiang and Zeng 1995; Wu et al. 2005). Extension of our Bayesian method to 
multiple traits will be pursued.
Body weight QTL
At least three subsets of QTL influencing growth in mice were found, including those that 
act early in life, those that act later in life, and those with effects throughout ontogeny. Such 
findings confirm previous reports (Cheverud et al., 1996; Vaughn et al., 1999; Morris et al., 
1999; Rocha et al., 2004a; Brockmann et al., 2004). The presence of such subsets of genes is 
not surprising given the low phenotypic and genetic correlations that were found between 
early and late body weights or growth rates in these data (Leamy et al., 2002) and other 
studies (Rutledge et al., 1972; Atchley et al., 1984; Cheverud et al., 1996). Atchley et al. 
(1997) provided further evidence for independent genes affecting early and late growth by 
successfully using selection indexes to modify early growth while constraining changes in 
growth at a later age. Furthermore, it is clear that early and late growths are, in part, 
regulated by different underlying physiological mechanisms (Cheverud, 2005).
For the most part, QTL influencing early growth were manifested by larger body weights in 
heterozygotes, or those mice with a genetic contribution from CAST, while QTL affecting 
later growth almost always led to higher body weight when in the homozygous M16i 
Yi et al. Page 9













genotype. Larger body weights for heterozygotes compared to homozygous M16 mice may 
represent a fitness advantage in that larger mice would have a higher survival rate than 
smaller mice during preweaning growth. The larger body weights of M16i-based alleles for 
later growth stages are not surprising. The basis for selection in the M16i line was for weight 
gain during the period of major postnatal growth from 3 to 6 weeks of age, and a correlated 
response to this selection is that the mice are late-maturing (Eisen, 1986). Therefore, it 
would be expected that loci influencing growth rates from 3 to 6 weeks as well as at later 
stages would be positive for M16i homozygous mice. This influence was the case for most 
growth rate QTL, with a clear exception on Chromosome 1, where the heterozygous 
genotype led to faster 3–6 wk growth rate, and the advantage for the M16i homozygous 
genotype was not manifested until mid-to late-life. The advantage for heterozygotes and/or 
CAST-based alleles at early growth periods (mainly preweaning) may be due to two 
interrelated explanations. First, CAST mice originated as a natural wild population and has 
likely had selective pressure placed on very early growth rate due to increased prenatal and 
neonatal competition and death. Furthermore, overdominance is likely to be of greater 
importance for traits influencing fitness (Lerner, 1954) and would thus have greater 
importance in early as opposed to later growth rates. Indeed, Cheverud et al. (1996) have 
shown that overdominance was most prevalent for QTL affecting early growth rate in their 
specific cross between LG and SM lines of mice. While we cannot separate overdominance 
from an additive effect with an advantage to the CAST allele, our data are again in general 
agreement with those of Cheverud et al. (1996).
The epistatic QTL effects on body weight in general agree with previous findings in mice 
(Cheverud et al., 1996; Brockmann et al., 2000, 2004; Ishikawa et al., 2005). In a backcross 
between M. m. castaneus and C57BL/6J, Ishikawa et al. (2005) detected a higher degree of 
epistatic QTL for juvenile growth compared to adult growth, which contrasts with the 
greater degree of epistasis for adult body weights than for juvenile weights found in the 
present study. The contrasting results may be associated with selection for postweaning 
growth in M16 causing the buildup of epistatic complexes as ontogeny progresses.
Adiposity QTL
The present study adds to the growing compilation of QTL affecting adiposity in mice (e.g., 
Brockmann & Bevova, 2002; Rocha et al., 2004b). Most QTL affecting fatness have small 
additive effects, and several can be modified by diet, age, and sex (Bünger & Hill, 2005). 
However, several studies have found significant epistatic interactions for fat deposits and 
related traits in mice and other mammalian species (Brockmann et al., 2000, 2004; Cheverud 
et al., 2001; Yi et al., 2004a, b). Dong et al. (2003, 2005) reported two instances of epistasis 
between obesity susceptibility loci in humans. Four pairs of interacting loci for non-insulin 
dependent diabetes were detected in the Otsuka Long-Evans Tokushifa fatty rat (Yamada et 
al., 2001).
The present data clearly indicate two types of adiposity genes with respect to body mass. 
One set of adiposity QTL exhibit pleiotropy with body weight, which was expected based on 
positive genetic correlations and positive realized correlated responses previously reported 
(Eisen &Leatherwood, 1978a, b; Eisen 1987). The other type of QTL for fatness is 
Yi et al. Page 10













independent of body weight. Eisen et al. (1995) provided support for adiposity genes that are 
independent of body weight by successfully applying restricted selection to increase gonadal 
fat without altering body weight. Reducing fat content while holding body weight constant 
proved more elusive, possibly due to sensitivity of the index to changes in genetic 
parameters (Eisen et al., 1995).
An interesting finding from this study was that epistatic interactions involving CAST alleles 
seemed to increase obesity (see Table 3). However, results may again be confounded with 
dominance given that, in this backcross, all CAST alleles must appear in conjunction with an 
M16i allele. Evaluation of epistasis in an F2 intercross would be more powerful than the 
current design, as it would enable comparison of the additive and dominance nature of 
epistatic interactions. We are currently performing such analyses using the cross described 
by Rocha et al. (2004a,b). Although the presence of CAST alleles on chromosome 2 
appeared to outweigh the impact of the CAST alleles from other chromosomes on epistatic 
interactions, this likely reflects the very strong role of chromosome 2 on growth and obesity 
in this and other crosses involving the M16i line (Rocha et al., 2004a,b). This region of the 
mouse genome appears to contain many genes involved in regulation of energy balance 
(Pomp et al., 2004; Jerez-Timaure et al., 2005).
Other consistencies of results can be found with the study of Rocha et al. (2004 a, b), who 
crossed M16i and a second line selected for low 6 week body weight (L6). Our results 
reproduced the findings regarding coincidence of QTL locations impacting obesity traits. 
The QTL for adiposity index located on chromosomes 2, 7, and 15 appeared to be in 
common. Also, the magnitude of concordance regarding QTL for liver weight was very 
high. In contrast, it is not surprising that there were some discrepancies between the various 
studies employing the M16i line, due to different lines used for the cross (i.e., CAST/Ei 
versus L6), different adjustments of phenotypic data, and the lack of statistical detection of 
epistatic interactions in the study of Rocha et al. (2004 a, b).
The QTL data here provide a possible explanation of why selection for increased body 
weight in mice does not always lead to a positive correlated response in adiposity (e.g., 
Eisen et al., 1978), even though the two traits are genetically positive correlated. If the QTL 
alleles having a positive pleiotropic effect on adiposity and body weight are fixed or are at a 
low frequency such that genetic drift could cause loss of these alleles in early generations of 
selection, then directional selection for growth would lead to an absence of a correlated 
response in obesity.
Except for the interaction between chromosomes 1 and 18, which was shared for body 
weight and adiposity, different epistatic interactions were detected for different traits. Given 
that genetic correlations among these traits are high but far from unity (Eisen & Prasetyo, 
1988), this evidence for partially independent pathways of interactive genetic control in 
addition to shared covariance is to be expected.
Organ QTL
Leamy et al. (2002) estimated QTL for organ weights using these data and an interval 
mapping analysis (Haley & Knott, 1992). Although they detected more significant QTL, 
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likely due to use of principal components of all organ weights as a “new” phenotype, the 
chromosomal regions detected by the two analyses appear to be very similar, e.g., 
chromosomes 1, 2, 4, 9, 11 and 18. Although QTL for liver weight on chromosomes 2 and 
11 were highly associated with total body mass, all QTL for heart and testes weights, and 
some QTL for weights of kidney and spleen, were independent of body weight. Results were 
comparable to those reported by Brockmann et al. (2000).
Conclusions
The primary objective of this work was to apply Bayesian analyses of multiple epistatic 
QTL models to data on body weight and body composition in mice. Although we have 
uncovered statistical evidence for epistatic interactions contributing to the control of body 
weight and fatness, comprehensive functional analyses in the relevant regions must be 
undertaken to determine the underlying loci and how they interact. Fine-mapping is being 
actively pursued with congenic lines (Jerez-Timaure et al., 2005), but this targets QTL with 
large main effects and not necessarily those with strong involvement on epistasis. The 
approach of integrating large-scale transcriptional phenotypes with QTL mapping (Schadt et 
al., 2003; Pomp et al., 2004) may be very powerful in discovering the genes involved in 
epistatic interactions.
For all analyses, QTL with strong main effects on the phenotypes were identified on the 
same chromosomes no matter which method was applied. However, additional putative QTL 
with relatively small influences on phenotypic variation were discovered only when 
assessing main effects and epistatic effects simultaneously, indicating that genes of small 
effect may only be detectable in models accommodating epistasis. The results of this study 
have thus not only added novel QTL to the map of obesity predisposition in the mouse, but 
have provided some insights into potential interactions among genes that contribute to 
regulation of body weight and fatness. When comparing these results to other initial 
evaluations in other genetic crosses, different patterns of epistatic interactions emerge, 
suggesting the possibility of yet higher order interactions as may be expected given the 
complex nature of the biochemical pathways regulating these traits. Given the important role 
that gene-gene interactions may play in regulating complex traits, it is clear that statistical 
models incorporating analysis of epistasis should be a focus of attention in future QTL 
analyses.
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Genome-wide epistatic analysis of body weights: profiles of posterior inclusion probability, 
cumulative probability function, posterior means of main effect and proportion of 
phenotypic variance explained by main effect (PPV%). On the x-axis, outer tick marks 
represent chromosomes and inner tick marks represent markers. 12d, 3wk, 6wk, 9wk and 
12wk represent body weights at day 12 and at 3, 6, 9 and 12 weeks of age, respectively.
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Genome-wide epistatic analysis of fat traits under model without adjustment for body 
weight at 12 weeks: profiles of posterior inclusion probability, cumulative probability 
function, posterior means of main effect and proportion of phenotypic variance explained by 
main effect (PPV%). On the x-axis, outer tick marks represent chromosomes and inner tick 
marks represent markers. GON, SUB and FAT represent perimetrial fat pad, right hindlimb 
subcutaneous fat pad and the sum of the two fat pads, respectively.
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Genome-wide epistatic analysis of fat traits under model including adjustment for body 
weight at 12 weeks: profiles of posterior inclusion probability, cumulative probability 
function, posterior means of main effect and proportion of phenotypic variance explained by 
main effect (PPV%). On the x-axis, outer tick marks represent chromosomes and inner tick 
marks represent markers. GON, SUB and FAT represent perimetrial fat pad, right hindlimb 
subcutaneous fat pad and the sum of the two fat pads, respectively.
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Genome-wide epistatic analysis of organ weights under model excluding adjustment for 
body weight at 12 weeks: profiles of posterior inclusion probability, cumulative probability 
function, posterior means of main effect and proportion of phenotypic variance explained by 
main effect (PPV%). On the x-axis, outer tick marks represent chromosomes and inner tick 
marks represent markers. HRT, LIV, SPL, TES and KID represent weights of heart, liver, 
spleen, testis and kidney, respectively.
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Genome-wide epistatic analysis of organ weights under model including adjustment for 
body weight at 12 weeks: profiles of posterior inclusion probability, cumulative probability 
function, posterior means of main effect and proportion of phenotypic variance explained by 
main effect (PPV%). On the x-axis, outer tick marks represent chromosomes and inner tick 
marks represent markers. HRT, LIV, SPL, TES and KID represent weights of heart, liver, 
spleen, testis and kidney, respectively.
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Table 2
Interval mapping of body weight: Locations (cM), LOD scores, confident intervals (CI) of QTL.
Traita Chromosome Location LODb CIc
12d 4 17 3.41 11–41
18 22 3.34 6–72
18 48 4.27 19–65
3wk 1 72 5.74 57–86
18 45 4.71 13–60
6wk 1 68 7.26 52–81
2 43 3.40 36–64
2 60 3.34 36–64
9wk 2 62 13.65 54–66
2 78 10.63 72–85
15 42 3.54 32–62
15 58 3.36 32–62
12wk 2 66 16.20 59–68
2 77 15.21 74–83
11 23 4.14 7–52
15 43 4.16 34–62
15 56 3.93 34–62
a
Body weights at day 12 and at 3, 6, 9 and 12 weeks of age (12d, 3wk, 6wk, 9wk and 12wk).
b
The LOD 3.3 criterion is used for significance.
c
cM location where the LOD score is one less than the peak.
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Table 5
Epistatic analysis of body weights: cumulative posterior inclusion probability, posterior mean of epistatic 
effect, and proportion of phenotypic variance explained by the epistasis (PPV%).
Traita Chromosome pair Posterior probability Epistasis PPV
12d 2 × 14 0.244 −0.499 1.8
3wk 3 × 13 0.252 −0.619 2.7
6wk 1 × 2 0.471 −0.627 2.8
2 × 13 0.145 −0.435 1.3
13 × 18 0.252 −0.718 3.5
9wk 1 × 4 0.121 0.467 1.6
1 × 11 0.424 0.598 2.3
1 × 18 0.631 0.817 4.1
2 × 13 0.402 −0.573 2.2
12wk 1 × 4 0.434 0.680 3.1
1 × 18 0.530 0.722 3.4
2 × 13 0.210 −0.485 1.6
13 × 15 0.107 −0.410 1.2
a
Body weights at day 12 and at 3, 6, 9 and 12 weeks of age (12d, 3wk, 6wk, 9wk and 12wk).
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